/
/
/

Transgene Biotek Balance Sheet

Consolidated
Standalone
₹
%

Share Price Live Stats

Open (₹)2.53
Volume (₹)16,560.00
High (₹)2.54
Upper Circuit3.13
Low (₹)2.53
Lower Circuit2.09
Prev Close2.61
52W High (₹)4.39
Price2.53
52W Low (₹)1.83

Share Market Cap & Key Ratios Overview

M.Cap (₹)19.78 Cr
Div. Yield (%)0.00
PE Ratio0.00
Debt to Equity1.45
Price to Book2.53
Book Value1.32
EPS (TTM)-0.21
Face Value10.00
ROE (%)-6.52

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SAGILITY-ANSE
SYNGENE-ANSE
INDGN-ANSE
IGIL-ANSE
NESCO-ANSE
JUSTDIAL-ANSE
LATENTVIEW-ANSE
CMSINFO-ANSE
MEDIASSIST-ANSE
AWFIS-ANSE
TRABI-XNSE
LTP
1W Low
1W High
Market cap (₹)
44.93-0.7 (-1.53%)
44.71
46.67
21,019Cr
379.8+10.55 (2.86%)
360.35
387
15,356Cr
601.55+4.05 (0.68%)
587.35
609
14,300Cr
324.7-6.25 (-1.89%)
322.20
334
14,045Cr
1085-14.15 (-1.29%)
1062.45
1113.65
7,558Cr
664.55-4.7 (-0.70%)
661.85
700
5,728Cr
242.7-12.55 (-4.92%)
242.70
256.15
5,085Cr
230.1-0.6 (-0.26%)
230
237.40
3,720Cr
321.65-2.7 (-0.83%)
317.75
342.95
2,393Cr
260-16.3 (-5.90%)
255
282.55
1,874Cr
2.53-0.2 (-7.33%)
2.53
3.05
20Cr

Key Highlights of Transgene Biotek Ltd Balance Sheet

Transgene Biotek Ltd balance sheet discloses shareholders' funds of ₹75.77Cr as of 2025-03-31. The company’s equity share capital is at a value of ₹75.77Cr, and the reserves and surplus of the company is -₹83.32Cr.

The company has its non-current liabilities with total liabilities of ₹34.2Cr as of 2025-03-31.

The current liabilities are ₹12.62Cr as of 2025-03-31. At the same time, current assets are ₹1.26Cr as of 2025-03-31.

Key assets on the balance sheet are non-current investments of ₹9.5Lakh and tangible assets of ₹7.96Cr, provided in the Transgene Biotek Ltd financial statements.